…TIMESLOT: Wednesday 26 November 2025 16:00 CET
…MAIN TITLE: Innovative therapies in Myasthenia Gravis
…PRESENTERS: Prof. Dr. med. Andreas Meisel (Charité – Universitätsmedizin Berlin (CCM), Germany)
Andreas Meisel is a professor of neurology at the Center for Stroke Research Berlin (CSB) and NeuroCure Clinical Research Center (NCRC), and an attending physician and neurointensivist in the Department of Neurology with Experimental Neurology. He is chairman of the Berlin Stroke Alliance. His group is active in experimental and clinical stroke research unravelling mechanisms of stroke induced immune changes and its functional relevance for post-stroke complications as well as brain repair. Meisel’s group is developing novel diagnostic biomarkers and treatments for post-stroke complications. Moreover, he aims at establishing comprehensive care approaches for stroke survivors in the chronic phase of the disorder.